The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Rappard-Van Der Veen, F. M.
Right arrow Articles by Gleichmann, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Rappard-Van Der Veen, F. M.
Right arrow Articles by Gleichmann, E.

The Journal of Immunology, Vol 130, Issue 6 2693-2701, Copyright © 1983 by American Association of Immunologists


ARTICLES

Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice

FM Van Rappard-Van Der Veen, T Radaszkiewicz, L Terraneo and E Gleichmann

By induction of a suitable graft-vs-host reaction (GVHR) in nonirradiated, H-2-incompatible F1 mice, one can induce a syndrome strongly resembling systemic lupus erythematosus (SLE). The aim of the present study was to standardize the kind and number of DBA/2 donor cells required for optimal induction of this SLE-like GVH disease (GVHD). Groups of adult (C57BL/10 x DBA/2)F1 (BDF1) mice were injected i.v. with increasing numbers of DBA/2 spleen and lymph-node cells. We found that doses of 100 x 10(6) to 180 x 10(6) spleen and lymph-node cells provided a suitable donor-cell inoculum, whereas doses of donor cells below 100 x 10(6) were suboptimal and doses higher than 180 x 10(6) cells were supraoptimal for the induction of SLE-like GVHD. In a number of those F1 recipients that had received the donor-cell inocula composed of spleen cells, the duration of autoantibody formation was surprisingly brief. This appeared to be due to the fact that these GVH F1 mice were rapidly repopulated by lympho-hemopoietic donor cells. Even after the highest doses of DBA/2 spleen and lymph-node cells administered, this repopulation was not preceded by symptoms of acute GVH disease. Repopulation was avoided and a severe SLE-like disease induced when a mixture deficient in hemopoietic cells, i.e., 280 x 10(6) DBA/2 lymph-node and thymus cells, was used as donor-cell inoculum. Taken together, we reached three conclusions. First, the induction of full-blown SLE-like GVHD depends not only on the injection of a sufficient number of donor T cells but also on the continuous presence of F1 lymphoid cells, which seem to serve as stimulator cells. Second, in addition to the lymphoid hyperplasia and immune-complex glomerulonephritis (ICGN) described previously, the GVHR-induced lesions presenting themselves in the context of SLE-like autoimmunity include a Sjogren-like lymphoid infiltration of the salivary gland, a ubiquitous periarteritis, and a lymphoid infiltration of the bile ducts that is reminiscent of primary biliary cirrhosis. Third, the repopulation by donor cells of nonirradiated, H-2-incompatible hosts need not be accompanied by GVH mortality or symptoms of acute GVHD.


This article has been cited by other articles:


Home page
J. Immunol.Home page
R. Puliaev, I. Puliaeva, L. A. Welniak, A. E. Ryan, M. Haas, W. J. Murphy, and C. S. Via
CTL-Promoting Effects of CD40 Stimulation Outweigh B Cell-Stimulatory Effects Resulting in B Cell Elimination and Disease Improvement in a Murine Model of Lupus
J. Immunol., July 1, 2008; 181(1): 47 - 61.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Brukamp, A. M. Doyle, R. D. Bloom, N. Bunin, J. E. Tomaszewski, and B. Cizman
Nephrotic Syndrome after Hematopoietic Cell Transplantation: Do Glomerular Lesions Represent Renal Graft-versus-Host Disease?
Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 685 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Lang, P. Nguyen, J. C. Papadimitriou, and C. S. Via
Increased Severity of Murine Lupus in Female Mice Is Due to Enhanced Expansion of Pathogenic T Cells
J. Immunol., December 1, 2003; 171(11): 5795 - 5801.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Feuerstein, D. Shivers, F. Chen, R. A. Eisenberg, and T. H. Finkel
Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors
Int. Immunol., August 1, 2003; 15(8): 975 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. J. Lang, P. Nguyen, R. Peach, W. C. Gause, and C. S. Via
In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function
J. Immunol., April 15, 2002; 168(8): 3786 - 3792.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Tschetter, E. Mozes, and G. M. Shearer
Progression from Acute to Chronic Disease in a Murine Parent-into-F1 Model of Graft-Versus-Host Disease
J. Immunol., November 15, 2000; 165(10): 5987 - 5994.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Okubo, E. Hagiwara, S. Ohno, T. Tsuji, A. Ihata, A. Ueda, A. Shirai, I. Aoki, K. Okuda, J.-i. Miyazaki, et al.
Administration of an IL-12-Encoding DNA Plasmid Prevents the Development of Chronic Graft-Versus-Host Disease (GVHD)
J. Immunol., April 1, 1999; 162(7): 4013 - 4017.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Meyers, J. E. Tomaszewski, J. D. Glass, and C. W. Chen
The Nephritogenic T Cell Response in Murine Chronic Graft-Versus-Host Disease
J. Immunol., November 15, 1998; 161(10): 5321 - 5330.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F. Furukawa
Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity
Lupus, January 1, 1997; 6(2): 193 - 202.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1983 by The American Association of Immunologists, Inc. All rights reserved.